Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNTR
3251
DELISTED
Venator Materials PLC
VNTR
| $2.12M | ﹤0.01% |
447,746
+33,979
| +8% | +$163K |
|
3252
Five Star Bancorp
FSBC
$1.14B
| $2.12M | ﹤0.01% |
+87,704
| New | +$2.27M |
|
3253
Canadian Solar
CSIQ
$1.02B
| $2.11M | ﹤0.01% |
47,148
+194
| +0.4% | +$7.94K |
|
3254
First Advantage
FA
$3.4B
| $2.1M | ﹤0.01% |
+105,726
| New | +$2.15M |
|
3255
Stantec
STN
$8.04B
| $2.1M | ﹤0.01% |
45,759
+4,693
| +11% | +$212K |
|
3256
ACNB Corp
ACNB
$656M
| $2.1M | ﹤0.01% |
75,100
-56,845
| -43% | -$1.61M |
|
3257
AerSale
ASLE
$293M
| $2.09M | ﹤0.01% |
167,437
+81,167
| +94% | +$992K |
|
|
TIO
3258
DELISTED
Tingo Group, Inc. Common Stock
TIO
| $2.08M | ﹤0.01% |
888,923
+87,315
| +11% | +$168K |
|
3259
Exagen
XGN
$109M
| $2.08M | ﹤0.01% |
138,750
+55,799
| +67% | +$856K |
|
3260
BeyondSpring
BYSI
$47.3M
| $2.07M | ﹤0.01% |
198,094
+25,741
| +15% | +$272K |
|
|
CLSD
3261
DELISTED
Clearside Biomedical
CLSD
| $2.06M | ﹤0.01% |
28,236
+3,921
| +16% | +$182K |
|
3262
American Coastal Insurance
ACIC
$515M
| $2.06M | ﹤0.01% |
360,671
+16,930
| +5% | +$104K |
|
3263
Ternium
TX
$9.67B
| $2.05M | ﹤0.01% |
53,220
+11,553
| +28% | +$441K |
|
3264
Harrow
HROW
$1.45B
| $2.03M | ﹤0.01% |
218,217
-157,218
| -42% | -$1.34M |
|
3265
Ambev
ABEV
$48.1B
| $2.01M | ﹤0.01% |
585,688
-63,214
| -10% | -$206K |
|
3266
AtaiBeckley Inc
ATAI
$2.66B
| $2.01M | ﹤0.01% |
+108,543
| New | +$2.01M |
|
3267
LifeMD
LFMD
$169M
| $1.99M | ﹤0.01% |
169,013
+13,915
| +9% | +$160K |
|
3268
Genmab
GMAB
$17.7B
| $1.99M | ﹤0.01% |
48,610
-12,969
| -21% | -$500K |
|
|
RAIN
3269
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $1.98M | ﹤0.01% |
+127,718
| New | +$2.24M |
|
|
FNCH
3270
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $1.98M | ﹤0.01% |
+4,684
| New | +$2.03M |
|
|
PROS
3271
DELISTED
ProSight Global, Inc.
PROS
| $1.97M | ﹤0.01% |
154,653
+4,181
| +3% | +$53.3K |
|
|
CODX
3272
Co-Diagnostics
CODX
$5.31M
| $1.97M | ﹤0.01% |
7,940
-6,577
| -45% | -$1.69M |
|
|
VINC
3273
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $1.96M | ﹤0.01% |
7,539
+2,841
| +60% | +$866K |
|
|
IAS
3274
DELISTED
Integral Ad Science
IAS
| $1.96M | ﹤0.01% |
+105,000
| New | +$2.16M |
|
3275
Nano X Imaging
NNOX
$68.2M
| $1.94M | ﹤0.01% |
60,456
+21,466
| +55% | +$653K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.